BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8355396)

  • 21. Apolipoprotein epsilon 4 homozygosity--a determinant of restenosis after coronary angioplasty.
    van Bockxmeer FM; Mamotte CD; Gibbons FR; Taylor RR
    Atherosclerosis; 1994 Oct; 110(2):195-202. PubMed ID: 7848369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty.
    Desmarais RL; Sarembock IJ; Ayers CR; Vernon SM; Powers ER; Gimple LW
    Circulation; 1995 Mar; 91(5):1403-9. PubMed ID: 7867180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of restenosis after coronary angioplasty. A study on demographic and metabolic variables.
    Johansen O; Abdelnoor M; Brekke M; Seljeflot I; Høstmark AT; Arnesen H
    Scand Cardiovasc J; 2001 Mar; 35(2):86-91. PubMed ID: 11405502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum lipids and lipoproteins in relation to restenosis after coronary angioplasty.
    Johansson SR; Wiklund O; Karlsson T; Hjalmarson A; Emanuelsson H
    Eur Heart J; 1991 Sep; 12(9):1020-8. PubMed ID: 1936002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Normalization of lipid metabolism disturbances and clinical course after percutaneous coronary angioplasty: 6 month observation].
    Ochała A; Gabrylewicz B; Bartnik M; Garbocz P; Wycisk A; Lewicki A; Kaźmierski M; Tendera M
    Pol Arch Med Wewn; 2000 Dec; 104(6):833-41. PubMed ID: 11424662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of pravastatin on prevention of restenosis after successful percutaneous transluminal coronary angioplasty.
    Onaka H; Hirota Y; Kita Y; Tsuji R; Ishii K; Ishimura T; Kawamura K
    Jpn Circ J; 1994 Feb; 58(2):100-6. PubMed ID: 8196151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can aggressive lipid lowering using low-density lipoprotein apheresis prevent restenosis after percutaneous transluminal coronary angioplasty in patients with normocholesterolemia?
    Yamashita K; Tasaki H; Tsuda Y; Himeno E; Nakashima Y
    Ther Apher; 1998 Aug; 2(3):210-7. PubMed ID: 10227772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of serum lipid concentrations on restenosis after successful de novo percutaneous transluminal coronary angioplasty in patients with total cholesterol 160 to 240 mg/dl and triglycerides < 350 mg/dl.
    Dzavik V; Teo KK; Yokoyama S; Modi R; Dinwoodie A; Burton JR; Tymchak WJ; Montague TJ
    Am J Cardiol; 1995 May; 75(14):936-8. PubMed ID: 7733005
    [No Abstract]   [Full Text] [Related]  

  • 29. Restenosis after transluminal coronary angioplasty: a risk factor analysis.
    Gürlek A; Dağalp Z; Oral D; Omürlü K; Erol C; Akyol T; Tutar E
    J Cardiovasc Risk; 1995 Feb; 2(1):51-5. PubMed ID: 7606641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homocysteine, lipoprotein(a), and restenosis after percutaneous transluminal coronary angioplasty: a prospective study.
    Miner SE; Hegele RA; Sparkes J; Teitel JM; Bowman KA; Connelly PW; Banijamali H; Lau HK; Chisholm RJ; Babaei S; Strauss BH
    Am Heart J; 2000 Aug; 140(2):272-8. PubMed ID: 10925342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced secretion of insulin plays a role in the development of atherosclerosis and restenosis of coronary arteries: elective percutaneous transluminal coronary angioplasty in patients with effort angina.
    Nishimoto Y; Miyazaki Y; Toki Y; Murakami R; Shinoda M; Fukushima A; Kanayama H
    J Am Coll Cardiol; 1998 Nov; 32(6):1624-9. PubMed ID: 9822088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prior restenosis predicts restenosis after coronary angioplasty of a new significant narrowing.
    Bresee SJ; Jacobs AK; Garber GR; Ruocco NA; Mills RM; Bergelson BA; Ryan TJ; Faxon DP
    Am J Cardiol; 1991 Nov; 68(11):1158-62. PubMed ID: 1951074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Identification of predictive factors associated with recurrent restenosis after second percutaneous transluminal coronary angioplasty].
    Kishi K; Hiasa Y; Tanaka H; Kinoshita M; Tanimoto M; Wada T; Aihara T
    J Cardiol; 1997 Jan; 29(1):7-12. PubMed ID: 9023674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical prognosis of moderate restenosis after percutaneous transluminal coronary angioplasty].
    Fukuzawa S; Ozawa S; Katagiri M; Watanabe H
    J Cardiol; 1995 Feb; 25(2):63-8. PubMed ID: 7897608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial.
    Yokoi H; Daida H; Kuwabara Y; Nishikawa H; Takatsu F; Tomihara H; Nakata Y; Kutsumi Y; Ohshima S; Nishiyama S; Seki A; Kato K; Nishimura S; Kanoh T; Yamaguchi H
    J Am Coll Cardiol; 1997 Oct; 30(4):855-62. PubMed ID: 9316509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of enhanced insulin secretion during an oral glucose tolerance test as a predictor of restenosis after direct percutaneous transluminal coronary angioplasty during acute myocardial infarction in patients without diabetes mellitus.
    Osanai H; Kanayama H; Miyazaki Y; Fukushima A; Shinoda M; Ito T
    Am J Cardiol; 1998 Mar; 81(6):698-701. PubMed ID: 9527077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum lipoprotein (a) level and restenosis after percutaneous coronary intervention.
    Lolekha P; Leowattana W; Kangkagate C; Mahanonda N; Pokum S
    J Med Assoc Thai; 2001 Dec; 84 Suppl 3():S628-35. PubMed ID: 12002903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Is plasma lipoprotein (a) level a reliable indicator predicting restenosis after angioplasty?].
    Bussière JL; de Bourayne J; Monségu J; Corbé H; Berville JD; Lancelin B; Ricordel I; Ollivier JP
    Arch Mal Coeur Vaiss; 1996 Apr; 89(4):425-9. PubMed ID: 8763001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum from patients with restenosis after percutaneous transluminal coronary angioplasty stimulates proliferation of bovine vascular smooth muscle cells under low extracellular calcium condition.
    Shirotani M; Yui Y; Hattori R; Kawai C
    Jpn Circ J; 1991 Jun; 55(6):634-42. PubMed ID: 1875531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired fibrinolysis early after percutaneous transluminal coronary angioplasty is associated with restenosis.
    Sakata K; Miura F; Sugino H; Shinobe M; Shirotani M; Yoshida H; Mori N; Hoshino T; Takada A
    Am Heart J; 1996 Jan; 131(1):1-6. PubMed ID: 8553994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.